Surrey Heartlands

Joint Formulary & PAD

Lofepramine hydrochloride - Depression

You are here : Home > Formulary Search > Lofepramine hydrochloride - Depression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Oral suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :

Documentation

Webpage
Depression - Clinical Knowledge Summaries

PAD Profile

ChemicalSubstance :
Lofepramine hydrochloride
Indication :
Depression
Group Name :
Keywords :
tricyclic antidepressants, TCAs
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Depression
Supporting Documents :
1

Other Indications

Below are listed other indications that Lofepramine hydrochloride is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Depression.

Committee Recommendations (1)

01 Jul 15 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status Note - The Mood Hive and associated local depression and anxiety treatment guidelines have been removed from PAD. Updated guidelines and resources for treating and managing depression in adults are being developed by Surrey & Borders Partnership. For current advice, in line with NICE guidance, please see the Clinical Knowledge Summaries